441 related articles for article (PubMed ID: 21486385)
1. The APOL1 gene and allograft survival after kidney transplantation.
Reeves-Daniel AM; DePalma JA; Bleyer AJ; Rocco MV; Murea M; Adams PL; Langefeld CD; Bowden DW; Hicks PJ; Stratta RJ; Lin JJ; Kiger DF; Gautreaux MD; Divers J; Freedman BI
Am J Transplant; 2011 May; 11(5):1025-30. PubMed ID: 21486385
[TBL] [Abstract][Full Text] [Related]
2. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
[TBL] [Abstract][Full Text] [Related]
4. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
Ma J; Divers J; Palmer ND; Julian BA; Israni AK; Schladt D; Pastan SO; Chattrabhuti K; Gautreaux MD; Hauptfeld V; Bray RA; Kirk AD; Brown WM; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Guan M; Palanisamy A; Reeves-Daniel AM; Bowden DW; Langefeld CD; Hicks PJ; Ma L; Freedman BI
Kidney Int; 2015 Sep; 88(3):584-92. PubMed ID: 25853335
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Injury in APOL1-associated Kidney Disease.
Ma L; Divers J; Freedman BI
Transplantation; 2019 Mar; 103(3):487-492. PubMed ID: 30371607
[TBL] [Abstract][Full Text] [Related]
6. Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
Dorr CR; Freedman BI; Hicks PJ; Brown WM; Russell GB; Julian BA; Pastan SO; Gautreaux MD; Muthusamy A; Chinnakotla S; Hauptfeld V; Bray RA; Kirk AD; Divers J; Israni AK
PLoS One; 2016; 11(4):e0152775. PubMed ID: 27054572
[TBL] [Abstract][Full Text] [Related]
7. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.
Lee BT; Kumar V; Williams TA; Abdi R; Bernhardy A; Dyer C; Conte S; Genovese G; Ross MD; Friedman DJ; Gaston R; Milford E; Pollak MR; Chandraker A
Am J Transplant; 2012 Jul; 12(7):1924-8. PubMed ID: 22487534
[TBL] [Abstract][Full Text] [Related]
8. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
[TBL] [Abstract][Full Text] [Related]
9. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
10. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index.
Julian BA; Gaston RS; Brown WM; Reeves-Daniel AM; Israni AK; Schladt DP; Pastan SO; Mohan S; Freedman BI; Divers J
Am J Transplant; 2017 Jun; 17(6):1540-1548. PubMed ID: 27862962
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
Semin Nephrol; 2017 Nov; 37(6):530-537. PubMed ID: 29110760
[TBL] [Abstract][Full Text] [Related]
12. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
13. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
[TBL] [Abstract][Full Text] [Related]
14. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
[TBL] [Abstract][Full Text] [Related]
16. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
17. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
[TBL] [Abstract][Full Text] [Related]
18. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein L1: role in the evaluation of kidney transplant donors.
Lentine KL; Mannon RB
Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):645-655. PubMed ID: 33009133
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
